Biora Therapeutics, Inc. (BIOR)
NASDAQ: BIOR · Real-Time Price · USD
2.950
-0.380 (-11.41%)
At close: Nov 4, 2024, 4:00 PM
2.990
+0.040 (1.35%)
After-hours: Nov 4, 2024, 7:38 PM EST
Biora Therapeutics Revenue
Biora Therapeutics had revenue of $318.00K in the quarter ending June 30, 2024, with 15,800.00% growth. This brings the company's revenue in the last twelve months to $860.00K, up 777.55% year-over-year. In the year 2023, Biora Therapeutics had annual revenue of $4.00K, down -98.69%.
Revenue (ttm)
$860.00K
Revenue Growth
+777.55%
P/S Ratio
8.98
Revenue / Employee
$14,828
Employees
58
Market Cap
10.85M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Kiora Pharmaceuticals | 16.02M |
Dominari Holdings | 9.51M |
PAVmed | 3.83M |
RedHill Biopharma | 3.71M |
Alterity Therapeutics | 2.68M |
Senti Biosciences | 338.00K |
BioRestorative Therapies | 174.10K |
BIOR News
- 6 days ago - Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 7 days ago - Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting - GlobeNewsWire
- 2 months ago - Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire
- 3 months ago - Biora Therapeutics, Inc. (BIOR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Biora Therapeutics Announces Funding Agreement with Existing Investors - GlobeNewsWire
- 3 months ago - Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update - GlobeNewsWire
- 5 months ago - Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024 - GlobeNewsWire